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Introduction
Successful uterine implantation is a critical element of mammalian reproduction, without
which the embryo cannot continue its development. The process of implantation is a tightly
and highly coordinated event that is systematically and systemically driven by changes in
the hypothalamic-pituitary-gonadal axis (Belchetz et al., 1978; Bliss et al., 2010; Levine et
al., 1982; Levine and Ramirez, 1982; Midgley and Jaffe, 1971; Santen and Bardin, 1973).
Cyclic changes in the ovarian derived hormones progesterone (P4) and estrogen (E2) not
only direct follicular maturation and ovulation, but significantly, also cause changes to
uterine physiology that alter its normally non-receptive state to a environment receptive to
the conceptus (Chen et al., 2000; Das et al., 1994b; Lubahn et al., 1993; Lydon et al., 1995;
Psychoyos, 1973a, b; Song et al., 2000; Tranguch et al., 2005; Wang et al., 1994; Yoshinaga
and Adams, 1966; Yoshinaga et al., 1969). This receptive state lasts for a very short time
during the estrus cycle, and is thus defined as a “window of receptivity”.
Concomitantly, but in an initially separate process, the mouse embryo follows an intrinsic
differentiation program. After fertilization the zygote increases in cell number, initiates
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zygotic gene transcription, and undergoes two integral morphogenetic events: blastomere
compaction and blastocoel formation (Biggers et al., 1977; Ziomek and Johnson, 1980). As
a result, the formerly spherical embryo becomes a blastocyst comprised of the inner cell
mass and an encompassing layer of trophectoderm. The inner cell mass will give rise to the
embryo proper, while the trophectoderm will initiate implantation and give rise to the
extraembryonic structures (Hillman et al., 1972; Tarkowski and Wroblewska, 1967). Once
formed, the blastocyst will undergo a process of activation consisting of physiological
changes that enable it to attach to the uterine epithelium and invade into the underlying
stroma (Carson et al., 1993; Das et al., 1994b; Hamatani et al., 2004; Paria et al., 1993b;
Raab et al., 1996; Schultz and Armant, 1995; Schultz et al., 1997; Wang et al., 2000; Xie et
al., 2008).
For implantation to occur properly, the change in uterine receptivity and the activation of the
blastocyst must be very precisely coordinated. To accomplish this, the embryo and uterus
exist is in a state of continuous crosstalk consisting of signals that regulate each other’s
progress toward implantation. Disruption of this embryo-uterine dialogue disrupts the
process of implantation, diminishes fertility, and causes adverse ripple effects on
placentation and offspring viability (Song et al., 2002; Wang et al., 2004; Wang et al., 2007;
Wilcox et al., 1999; Ye et al., 2005).
Uterine receptivity in the mouse is initiated by a surge of nidatory E2 on the morning of
implantation which induces changes in gene expression and, in particular, expression of the
cytokine Leukemia Inhibitory Factor (LIF) in the glandular epithelium (Bhatt et al., 1991;
Shen and Leder, 1992; Stewart et al., 1992). LIF is the key regulator of receptivity
downstream of E2 signals, and is sufficient to trigger implantation in the absence of an E2
surge (Chen et al., 2000). It is a potent intercellular signaling molecule, with pleiotropic
effects on both uterine epithelium and stroma that are necessary for stromal cell
decidualization (Chen et al., 2000; Fouladi-Nashta et al., 2005), as well as for regulating
blastocyst activation and embryonic gene and protein expression (Hamatani et al., 2004).
The molecular pathways regulating uterine receptivity downstream of E2 and LIF have
begun to be elucidated, with the progesterone receptor (PR) and Indian Hedgehog (Ihh)
identified as key mediators of the receptivity response both in the epithelium (Franco et al.,
2010; Lee et al., 2006; Wakitani et al., 2008) and in the stroma (Franco et al., 2011; Large
and Demayo, 2011; Lydon et al., 1995). The importance of LIF, IHH, and PR to uterine
receptivity and blastocyst activation is demonstrated by the findings that mice lacking any of
these proteins are infertile due to failure of blastocyst attachment and decidualization.
While progress has been made in understanding the regulation of uterine receptivity, the
process of blastocyst activation itself remain poorly understood. Previous work indicates
that amino acids (AA) play an important role in blastocyst activation. Mouse embryos
cultivated in vitro require a specific and defined culture medium containing amino acids
(Gwatkin, 1966; Naeslund, 1979; Spindle, 1980; Spindle and Pedersen, 1973). This
embryonic requirement for AA is not simply nutritive, as AA exposure induces
trophectoderm motility through activation of mTOR-dependent signal transduction cascades
only after the embryo has reached the early blastocyst stage (Martin and Sutherland, 2001;
Martin et al., 2003). A short pulse (4–8 hr) of AA exposure is sufficient to induce motility in
the trophectoderm of the early blastocyst, leading to trophoblast outgrowth in an in vitro
model of in vivo implantation behavior (Martin and Sutherland, 2001; Martin et al., 2003).
The requirement for AA at this stage acts as a developmental checkpoint; when cultured in
vitro without AA supplementation, blastocysts remain in a quiescent state, from which
trophoblast motility can be induced at any time by adding AA to the culture medium. Once
induced, the effect of AA is not reversible, as removing AA will not then switch embryos
back to a quiescent state.
González et al. Page 2













Through an as yet incompletely defined mechanism, AA have long been known to regulate
the activity of mTOR (mammalian target of rapamycin); a highly conserved serine/threonine
protein kinase which phosphorylates specific downstream effectors and in turn promotes
overall cellular growth via the translation of specific populations of mRNAs. mTOR is
known to exist in two biochemically and functionally distinct protein complexes: mTORC1
and mTORC2 (Hara et al., 2002; Kim et al., 2002; Sarbassov et al., 2004), which have
distinct downstream targets and cellular effects. mTORC1 signaling is required for mouse
embryo implantation (Gangloff et al., 2004; Guertin et al., 2006), and has been implicated in
AA regulation of trophoblast motility (Martin and Sutherland, 2001). However, the
pathways linking amino acids to mTORC1 and then to motility have not been identified. We
show here that leucine and arginine, and in particular, uptake of leucine through the
SLC6A14 amino acid transporter, are each required individually and together are sufficient
to induce blastocyst activation. Importantly, leucine and arginine activate mTORC1 and are
rapamycin-sensitive, both individually and in combination, yet activate TE motility
independently of the well-characterized targets of mTORC1, p70S6K and 4EBP. Blastocyst
activation in vivo is accompanied by changes in mTOR localization, and these changes
occur on day 4.5 of gestation, after the onset of embryo attachment, suggesting that there are
two separate signals from the uterus regulating the phases of implantation.
Materials and Methods
Materials
ICR male and female mice were obtained from Taconic. Embryo culture medium (Martin
and Sutherland, 2001; Spindle, 1980; Stephens et al., 1995) was produced in house using
embryo tested essential amino acids, salts, bovine serum albumin (BSA), and mineral oil
purchased from Sigma Aldrich Chemicals (St. Louis, MO). Antibodies used for detection of
total and phosphorylated proteins via western blots against phospho-p70S6K Thr389
(#9205), p70S6K Total (#9202), phospho-4EBP 37/46 (#9459), and 4EBP total (#9452)
were purchased from Cell Signaling Technology (Boston, MA). Phospho-4EBP Ser 65 was
produced by Dr. Thurl Harris (University of Virginia). Antibodies used for protein
expression and localization of mTOR (#2972), Raptor (#24C12), Rictor (#53A2), and LST8
(#86B8) by western blot and immunofluorescence were also purchased from Cell Signaling
Technology. The antibody used to detect protein levels of SLC6A14 (#ab99102) via
immunoblot was purchased from Abcam (Cambridge, MA) and antibody to tubulin was
from Sigma. Bovine fibronectin, cycloheximide, NO711, BCH, and DMSO were purchased
from Sigma, and rapamycin was from Calbiochem (San Diego, CA). The antibodies used for
mTOR immunofluorescence were purchased from Cell Signaling Technology (#2983) and
Santa Cruz Biotechnology (#SC-136269) The superovulatory hormone PMSG was
purchased from CalBiochem and hCG was from Sigma. [3H]Arginine and [3H]leucine were
purchased from Perkin Elmer (Waltham, MA).
Embryo Culture
Embryos were flushed at the 2-cell stage from superovulated and mated female ICR mice
and cultured from 48 to 120h phCG as previously described (Martin and Sutherland, 2001;
Sutherland et al., 1993). 120h phCG embryos were then transferred to 10µl drops of serum
free medium supplemented with 4mg/ml BSA and amino acids and cultured for an
additional 8–48 hours depending on experimental design. After amino acid exposure
embryos were subjected to a trophoblast cell spreading assay. Medium containing a
complete mixture of amino acids will be designated +AA, and medium with no amino acids
−AA. −Arg, −Leu, or −Arg/ −Leu refers to medium excluding only arginine and/or leucine
individually while retaining all other amino acids. +Arg, +Leu or +Arg/+Leu refers to
medium containing only 0.2mM arginine and or leucine and no other amino acids.
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Rapamycin (RAPA 25nM) was used to inhibit mTOR, cycloheximide (CHX 50mg/ml) was
used to inhibit protein translation, and α-amanitin (10mg/ml) was used to inhibit
transcription. BCH and NO711 were used at a concentration of 100mM to inhibit SLC6A14
activity. All inhibitors were prepared from stock solutions in appropriate chemical vehicles
(DMSO or water) and then diluted in medium immediately prior to use.
Trophoblast Cell Spreading Assay
Substrates of bovine fibronectin were prepared as previously described (Martin and
Sutherland, 2001; Sutherland et al., 1993). Embryos were collected and cultured as
described above and transferred to 10µl drops of medium overlaying fibronectin coated
plastic at designated times and analyzed for trophoblast outgrowth at specific intervals.In
experiments using inhibitors (Rapa, CHX, α-amanitin, NO711, and BCH) embryos were
first incubated for 1h in −AA containing the specific inhibitor and then transferred to
medium with amino acids and containing the same inhibitor. After 8 hours the embryos were
washed three times in 550µl of medium either containing or not containing amino acids
depending on experimental protocol, and then transferred to fibronectin coated drops of
medium and analyzed for trophoblast outgrowth at various intervals over the next 48 hours
(Sutherland et al., 1993).
Western Blotting
Oocytes and 2-cell, 8-cell, morulae, and blastocyst stage embryos were collected over the
course of several weeks and stored at −80°C until needed, then prepared for immunoblotting
by lysing in homogenization buffer (50 mM NaF, 1mM EDTA, 1mM EGTA, 1mM DTT,
10mM sodium phosphate, 50 mM β-glycerolphosphate pH7.4, 1mM PMSF, 10µl/ml
phosphatase inhibitor cocktail, 10µg/ml proteinase inhibitor cocktail, 10µg/ml DNAse,
1%Tween-20). After lysis, lysate equivalent to 100 oocytes or embryos was loaded per lane
of a 4–12% NuPage Novex Bis-Tris gradient gel (#NP0323), run and then transferred to
PVDF membrane (Milipore, Billerica, MA). The membrane was blocked with 5% Non fat
milk solution in TBS/T (Blocking Buffer) for 1 hour at room temperature, then incubated at
4°C overnight in buffer (1× TBS with 5%BSA, 0.01% Tween-20) containing primary
antibody. After washing, the blot was incubated with HRP-conjugated donkey anti rabbit
secondary antibodies in blocking buffer (BioLegend, San Diego, MA) for 1 hour at room
temperature, washed again and then chemiluminescence (Pierce, Rockford, IL) was used to
detect the proteins of interest; SLC6A14, p70S6K, 4EBP, mTOR, Rictor, Raptor, Lst8 and
tubulin, as well as phosphorylated forms of p70S6K and 4EBP.
Uptake of [3H]Arginine and [3H]leucine
Embryos were cultured in various amino acid conditions for 8 hours from 120–128h phCG.
At 128h phCG, embryos were transferred to +AA medium containing [3H]arginine or
[3H]leucine substituted for non-radiolabeled arginine or leucine to the same concentration.
After 10 minutes incubation in [3H]AA medium, embryos were washed three times in 550µl
of cold −AA, then placed into scintillation vials and lysed with 100µl boiling 2%SDS.
Scintillation fluid (Ready Safe) was added, the vial was thoroughly vortexed, and the
radioactivity of the sample measured using a liquid scintillation counter (Beckman LS1801).
For inhibition experiments with BCH and NO711, embryos were first incubated with the
inhibitor in −AA medium for one hour at 120h phCG and then transferred for 8 hours into
amino acid containing medium from 121–129h phCG followed by a 10 minute pulse of [3H]
amino acid pulse and liquid scintillation detection as described above.
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Oocytes and embryos were fixed in 3.7% formaldehyde in immunofluorescence (IF) buffer
(40mM PIPES pH 6.8, 200mM NaCl, 2mM EGTA) for 15 minutes, washed three times in IF
buffer for 5 minutes, permeabilized with o.1% Triton X-100/IF buffer for 2 minutes, washed
three times in IF buffer for 5 minutes and blocked in 1 hour at room temperature in Super
Block (5%BSA, 20%FBS). Oocytes or embryos were then incubated in Super Block with
primary antibody added (1:200) overnight at 4°C. The next day they were washed three
times in 0.5% Tween20/IF Buffer for 5 minutes and placed in 0.5% Tween20/IF Buffer
solution with secondary antibody added (Invitrogen, Carlsbad, CA) for 1 hour at room
temperature. Lastly, oocytes and embryos were washed three times in 0.5% Tween20/IF
Buffer and 1X IF Buffer for five minutes, mounted in DAPI/PBS, and analyzed by confocal
and multiphoton microscopy.
Confocal Microscopy and Image Analysis
The imaging system consisted of a Zeiss Axiovert 200M epifluorescent motorized
microscope with a 100W Hg arc lamp and a halogen lamp. AC-Apochromat 63× water NA
1.2 objective lens was used for the studies described here. The Axiovert 200M was coupled
to a Zeiss510 confocal-multiphoton-spectral imaging system (www.zeiss.de), and the system
was controlled using the LSM software (version 4.0). For confocal imaging, the system
consisted of a 45mW argon laser (458, 488, 514 nm), a 10mW (561 nm) laser and a 633 nm
laser. We used 561 nm to excite the Alexa546 fluorophore donkey anti rabbit secondary
antibody. For two-photon imaging a 10W Verdi pumped, tunable (model 900 Mira,
www.coherentinc.com) modelocked ultrafast (78 MHz) pulsed (<150 femtosecond) laser
was coupled to the laser port of a Zeiss510 META/NLO. This laser was equipped with
optics for easy tunable range of the entire wavelength (700 to 1,000 nm). The system was
equipped with spectrum analyzer (Model E201; www.istcorp.com) to monitor the excitation
wavelength. We used two-photon 830 nm laser to excite the DAPI. Scanning confocal image
stacks were taken at 0.5micron intervals. Confocal data was then analyzed using Volocity
(Improvision, Waltham, MA) to render three-dimensional reconstructions and to capture
images.
Uterine fluid collection and spreading experiments
Uterine fluid was collected using methods previously described (Harris et al., 2005) from 8–
10 mice per stage at 48, 60, 72, 120, 130, and 144 h phCG. The fluid collected at each time
point was pooled together, spun down, and stored at −20°C under oil until just prior to use.
In vitro matured 120h phCG embryos were placed in 5µl drops of −AA medium on
fibronectin substrates, then the −AA medium was removed and replaced with the warmed
and CO2-equilibrated uterine fluid, and the embryos were then cultured and analyzed at
specific times for trophoblast outgrowth.
Statistical Analysis
For experiments examining trophoblast outgrowth and amino acid uptake, the data from a
minimum of three experiments done in triplicate were averaged and the standard deviation
calculated. The averages and standard deviations were analyzed for statistical significance
using one-tailed ANOVA and the Student-Newman-Keuls test (Glantz, 1992).
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Arginine and leucine are necessary and sufficient for blastocyst activation and trophoblast
outgrowth
Previous results have shown that amino acids are required at the early blastocyst stage (120h
post-hCG for superovulated embryos, Table 1) for the embryo to initiate the motility
required for implantation (Gwatkin, 1966; Martin and Sutherland, 2001; Martin et al., 2003;
Naeslund, 1979). Early results suggested that leucine and arginine were particularly
important for initiation of embryo outgrowth (Gwatkin, 1966; Naeslund, 1979). Excluding
either arginine or leucine, or both, from the culture medium results in quiescent embryos
that fail to form outgrowths when placed on a fibronectin substrate (Figure 1A) while
exclusion of other individual AA does not affect trophoblast motility. Notably, this includes
glutamine, which in previous work in cultured cells was found to be necessary for leucine
uptake (Nicklin et al., 2009). These data confirm that the availability of arginine and leucine
alone are most critical to the initiation of in vitro trophectoderm spreading.
Since arginine and leucine are required for trophoblast outgrowth, we tested whether these
amino acids were sufficient to induce trophectoderm spreading. An 8-hour pulse of either
arginine or leucine alone, at an optimal concentration of 0.2mM, partially rescues spreading
(Figure 1B). This effect is unique to either arginine- or leucine-containing medium, as
medium containing other individual AAs fail to induce trophoblast outgrowth (Figure 1B).
Notably, the effects of arginine and leucine are additive. When embryos are stimulated with
0.2mM arginine and leucine in combination for 8h, the number of embryos exhibiting
trophoblast outgrowth is significantly higher, while continuous combined exposure leads to
a complete rescue of trophoblast outgrowth to control levels. In contrast to results obtained
in cultured cells (Nicklin et al., 2009), glutamine does not synergize with leucine, and is
inhibitory to arginine (Figure 1B).Taken together, these data show that arginine and leucine
each contribute individually to the induction of trophoblast outgrowth, and their effects are
additive when in combination.
Leucine transport by the amino acid transporter SLC6A14 (ATBo,+) is required for
trophoblast outgrowth
Embryos take up and release amino acids via specific transporters. Embryos express a large
repertoire of transporters that vary in substrate preference, and importantly, change
according to embryonic stage (Van Winkle, 2001; Van Winkle et al., 1985; Van Winkle et
al., 2006). Leucine transport in particular, changes with the onset of the blastocyst stage,
becoming predominantly dependent on the SLC6A14 transporter (also designated ATB0,+).
SLC6A14 is a sodium-dependent, neutral and cationic amino acid transporter with a broad
specificity but with a high affinity for leucine, isoleucine, and methionine (Borland and
Tasca, 1974; Van Winkle et al., 1985; Van Winkle et al., 2006).
The activity of SLC6A14 is likely regulated at the level of transcription, as the message is
not detected during preimplantation development until the blastocyst stage (Martin et al.,
2003; Van Winkle et al., 1990a). Protein expression follows a similar pattern. Although 2-
cell embryos retain a robust amount of maternally inherited SLC6A14, it is rapidly degraded
by the 8-cell stage (Figure 2A). Levels of SLC6A14 protein remain low at the morula stage
but rapidly rise in the blastocyst, coincident with the onset of SLC6A14 gene transcription,
and with the onset of competency to receive activation signals (Martin and Sutherland,
2001). Exposing embryos to AA further increases SLC6A14 expression, suggesting that its
own translation may be affected by mTOR activity (Figure 2A).
To test whether leucine transport by SLC6A14 is central to trophoblast outgrowth, we used
NO711, a non-substrate inhibitor of SLC6A14 (Sloan, 2002), and BCH, a competitive
González et al. Page 6













inhibitor of leucine transport that has been previously shown to inhibit leucine uptake by
SLC6A14 (Sloan and Mager, 1999). NO711 treatment blocked leucine uptake (Figure 2D)
and trophoblast outgrowth both in the presence of all AA and in the presence of leucine
alone (Figure 2B and Supplemental Figure 1A). Embryos cultured in +Arg medium were
unaffected by the addition of NO711, consistent with the fact that arginine uptake is
predominantly through the Slc3a1/Slc7a9 (b0,+) heterodimeric amino acid transporter (Van
Winkle et al., 1990b). In +Leu/+Arg medium NO711 reduced spreading to levels
comparable to those in medium containing arginine alone (Figure 2B). Treatment of
embryos with BCH yielded similar results (Figure 2B).
We examined the specific requirement for SLC6A14 transport in two ways. First, we
cultured embryos in medium containing NO711 and increasing levels of leucine, which
resulted in greatly increased uptake of leucine through other transporters, but no increase in
trophoblast outgrowth (Figure 3A, B). Secondly, SLC6A14 also transports methionine and
isoleucine with similar Km/Ki to leucine (Sloan and Mager, 1999; Van Winkle et al., 1985;
Van Winkle et al., 1988; Van Winkle et al., 2006). However, embryos cultured in medium
containing arginine in combination with either methionine or isoleucine show no additive
effect on trophoblast outgrowth (Supplemental Figure 1B). These data show that leucine
transport specifically via SLC6A14 is critical for stimulation of trophoblast outgrowth as
well as for the combined action of arginine and leucine together.
Glutamine blocks the effects of arginine on trophoblast outgrowth
Eliminating glutamine from embryo culture does not affect TGC outgrowth, nor does
medium solely containing glutamine induce spreading (Figure 1A,B). Interestingly, when
embryos are cultured in the presence of 0.2mM arginine and 4.0mM glutamine, arginine
uptake and trophoblast outgrowth is completely inhibited (Figure 1B). Conversely glutamine
does not inhibit spreading either in complete amino acid conditions or in medium containing
a combination of leucine and glutamine (Figure 1B). Glutamine’s negative effects are
exclusive to arginine, and may explain why embryos fail to spread when leucine is
individually excluded from the culture medium despite the continued presence of arginine
(Figure 1A).
Arginine and leucine rescue is rapamycin sensitive
We previously showed that AA induced trophoblast outgrowth is a rapamycin sensitive
event, and thus is upstream of the serine/threonine kinase complex mTORC1. Rapamycin is
an immunophillic macrolide that allosterically inhibits mTORC1 activity by specifically
binding to the protein mTOR when complexed with Raptor and LST8 in the mTORC1
complex. Given that arginine and leucine are individually required for trophoblast
outgrowth, we hypothesized that each had a separate, required, action that together led to
blastocyst activation, and that one of these separate actions was mTOR activation. We tested
this hypothesis by culturing embryos in medium containing either arginine or leucine alone
or both in combination, and adding rapamycin to block mTORC1 activity. Rapamycin
completely blocked trophoblast outgrowth under all three conditions (Figure 4A). Thus the
effects of both arginine and leucine are rapamycin-sensitive, implying that each activates
mTORC1.
Arginine and leucine induction of trophoblast outgrowth is dependent upon translation but
independent of transcription
mTORC1 activates translation of specific populations of mRNAs, including TOP RNA and
cap dependent translation of mRNAs containing particularly complicated 5’ untranslated
regions (De Benedetti and Rhoads, 1990; Koromilas et al., 1992; Lazaris-Karatzas et al.,
1990). Induction of trophoblast outgrowth by +AA medium requires translation (Martin and
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Sutherland, 2001), so we hypothesized that the effect of arginine and/or leucine on
trophoblast outgrowth is similarly dependent upon translation. To test this, embryos were
cultured for 8 hours in medium known to promote spreading (+AA, +Arg, +Leu, and +Arg/
Leu) and cycloheximide (CHX) was added at concentrations known to inhibit mRNA
translation (Epstein and Smith, 1973). The presence of CHX inhibited trophoblast outgrowth
in all experimental groups (Figure 4B). These results indicate that the effect of both arginine
and leucine on trophoblast outgrowth requires protein translation. We next tested whether
transcription was necessary for the induction of trophoblast spreading. Embryos were
cultured for 8 hours in medium known to promote spreading (+AA, +Arg, +Leu, and +Arg/
Leu) and α-amanitin was added at concentrations known to inhibit mRNA transcription
(Flach et al., 1982; Levey and Brinster, 1978; Lindell et al., 1970). The presence of α-
amanitin did not affect spreading, indicating that the effects of arginine and leucine are
independent of transcription during the 8 hours of AA exposure (Figure 4C).
Phosphorylation of known downstream targets of mTORC1 fails to correlate with embryo
spreading
mTORC1’s effects on translation are accomplished via the phosphorylation of two well
established downstream effectors, p70S6K and 4EBP. p70S6K and 4EBP both regulate
protein translation (Lin et al., 1994; Pause et al., 1994). Phosphorylation by mTORC1 at
Thr389 activates p70S6K, which in turn phosphorylates ribosomal protein S6, and may
influence translation of TOP RNAs (De Benedetti and Rhoads, 1990; Koromilas et al., 1992;
Lazaris-Karatzas et al., 1990; Shama and Meyuhas, 1996) . Phosphorylation of 4EBP by
mTORC1 relieves its repression of eIF4E, and promotes cap dependant translation by
increasing the availability of eIF4E (Brunn et al., 1997; Pause et al., 1994). We next sought
to determine whether the phosphorylation states of p70S6K and 4EBP correlated with
embryo spreading. As expected, embryos stimulated with +AA medium exhibited a strong
amount of p70S6K phosphorylation at Thr389, which is decreased in embryos cultured in
−AA medium or in +AA medium containing rapamycin (Figure 5A,C). Under all other
culture conditions tested, phosphorylation of p70S6K was low. Under conditions where
trophoblast outgrowth is stimulated (+Arg, +Leu, and +Arg/+Leu) p70S6K was
phosphorylated to a similar degree as in –AA culture conditions (Figure 5C), while under
conditions lacking leucine or both arginine and leucine p70S6K was phosphorylated to an
even lower level (Figure 5A,C).Surprisingly however, p70S6K phosphorylation was fairly
robust in embryos cultured in medium lacking arginine, where embryos did not spread at all
(Figure 5 A,C).
mTORC1 phosphorylates 4EBP in a hierarchical fashion, first at Thr36/45 (Thr37/46 in
mouse) and Thr69, and then at Ser64 (Ser65 in mouse) to fully relieve its association with
eIF4E (Fadden et al., 1997; Gingras et al., 1999; Mothe-Satney et al., 2000b), and
phosphorylation of Thr69 and Ser64 are more sensitive to rapamycin (Mothe-Satney et al.,
2000a). 4EBP is phosphorylated both on Thr37/46 and Ser65 in embryos cultured in +AA
medium, and phosphorylation of both sites is decreased in embryos cultured in −AA
medium or in +AA medium containing rapamycin, with greater decreases in
phosphorylation seen for Ser65 in the presence of rapamycin, as expected (Figure 5 A, B,
C). Overall, though, the phosphorylation of 4EBP at both sites appears to be inversely
correlated with the ability of the embryo to initiate trophoblast outgrowth. Under conditions
where trophoblast outgrowth is partially rescued (+Arg, +Leu) 4EBP is only moderately
phosphorylated both on Thr37/46 and Ser65, with somewhat more robust phosphorylation in
the +Arg/+Leu combination group (Figure 5 A, B,C). However, 4EBP is strongly
phosphorylated at both Thr37/46 and Ser65 in embryos cultured under conditions where
trophoblast outgrowth is inhibited (-Arg, –Leu and – Arg/-Leu) (Figure 5 A, B,C). These
data indicate that despite the fact that arginine and/or leucine initiate a signal cascade that
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requires both mTORC1 and protein translation in order to produce changes in cell behavior
and motility, the activities of the well established downstream targets of mTORC1 that
mediate its effects on translation fail to correlate with the ability of the embryo to initiate
trophoblast outgrowth.
The amino acid sensitive mTORC1 components are preferentially expressed in the mouse
blastocyst
Since mTOR can form two functionally distinct complexes we next examined the
developmental profile of the various protein components of mTORC1 and mTORC2 to
provide insight into the relevance of these two complexes in relation to each other and with
respect to implantation. mTOR protein levels remain steady from oocyte to blastocyst while
Raptor protein levels specifically increase in morulae and blastocysts (Figure 6).
Conversely, levels of the mTORC2-specific subunit Rictor are relatively high in the oocyte
and 2-cell embryo, but diminished in the blastocyst (Figure 6). Interestingly, protein
expression of the common subunit LST8 also decreases in the blastocyst (Figure 6). It
appears that mTOR and Raptor are preferentially expressed in the implantation stage
embryo while Rictor and LST8 are not. These data are consistent with the results of mouse
knockouts (Gangloff et al., 2004; Guertin et al., 2006). Knockouts of mTOR and Raptor are
lethal at the peri-implantation stage, while knockouts of Rictor and LST8 are able to implant
normally and develop to mid-gestation. These findings suggest that mTOR and Raptor
functions are most critical to the implanting embryo and that the embryonic rapamycin-
sensitive mTORC1 is unique in that it may operate or exist without LST8.
mTOR localization changes throughout development and upon embryo activation
Although mTOR protein levels remain steady from oocyte to blastocyst, its cellular
distribution changes substantially during this period (Figure 6). Oocytes and embryos at 48
and 68h phCG (2-cell and 8-cell respectively, Table 1) exhibit diffuse cytoplasmic
localization of mTOR. As the embryo reaches 72h phCG (morula, Table 1) mTOR
localization begins to change from a diffuse distribution into aggregates of perinuclear
puncta (Figure 7). The 120h phCG embryo (early blastocyst, Table 1) retains this change in
localization with distinct perinuclear puncta and additional plasma membrane localization
(Figure 7). Stimulation of embryos with medium containing all AA results in a large
increase in immunofluorescent staining intensity (Figure 8B.). Embryos cultured in +AA
medium containing rapamycin (+AA Rapa) show an intermediate phenotype, with a modest
amount of increased mTOR signal (Figure 8C), as well as a loss of the plasma membrane
localization. The change in immunofluorescent signal intensity following AA exposure is
antibody-specific, and is consistently seen when using the rabbit monoclonal antibody 7C10
from Cell Signaling Technology. This antibody recognizes a region of the protein at the C-
terminus around the autophosphorylation site at Ser2481, phosphorylation of which is the
major indicator of mTOR activation (Yang and Guan, 2007). We verified that the change in
fluorescent intensity is not due to an overall change in protein expression in two ways. First
we examined protein expression directly by Western blot of whole cell lysate from embryos
cultured in either +AA or –AA, and found no difference in protein levels (Fig 8J). Second,
we performed double-label immunofluorescence using the Cell Signaling Technology anti-
mTOR antibody and a mouse monoclonal antibody from Santa Cruz Biotechnology
(#sc-136269) that was raised against amino acids 185–290 from the N-terminus of mTOR.
The localization of mTOR using the Santa Cruz antibody was similar to that seen with the
Cell Signaling antibody, but its staining intensity was similar in embryos cultured in –AA
and those cultured in +AA (Fig S3). Collectively these data suggest that the increase in
fluorescence seen when using the Cell Signaling Technology antibody may be due either to
a change in conformation of mTOR, to phosphorylation of Ser2481, or to an unmasking
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event following mTOR activation, any of which might allow the antibody to more
efficiently recognize its epitope.
Regardless of the underlying mechanism, the dramatic change in mTOR signal underscores
the effect of amino acids on mTORC1 activation, and also serves as a powerful tool to
monitor the activation state of mTOR directly in the embryo. Consistent with outgrowth
data, embryos cultured either in +Arg, +Leu, or +Arg+Leu medium exhibited an activated
pattern of mTOR immunostaining (Figure 9). Embryos cultured in −Leu, −Arg, or −Arg-
Leu medium also all exhibited an activated pattern of mTOR immunostaining (Figure 9).
This is consistent with the Western blot data showing phosphorylation of mTORC1 target
proteins, and confirms that mTORC1 activity is necessary but not sufficient to induce
blastocyst activation.
Embryos receive activation signals in vivo
Trophoblast outgrowth is an in vitro manifestation of the invasive behavior that the
trophoblast cells exhibit as they initiate implantation. Because the in vitro conditions under
which embryos are cultured are different than those that they encounter within the uterus, we
examined the dynamics of mTOR activation in embryos developing within the uterus. Mice
were superovulated and mated as before, but the embryos were then flushed from the uteri at
96, 120, and 130h phCG (Table 1), cultured for 8 hours in medium either containing AA or
not, and then transferred to a fibronectin substrate in medium lacking AA to assay the
induction of trophoblast outgrowth. Embryos flushed at 96h phCG embryos did not form
outgrowths after 8h culture in either medium, indicating that at this stage the embryo is not
yet competent to become activated, and also has not yet been activated in vivo (Figure 10A).
Embryos flushed at 120h post-hCG did spread following culture in +AA medium, but did
not when cultured in −AA medium (Figure 10A). Moreover mTOR staining of embryos
flushed at 120h phCG resembled that of in vitro cultured morulae and blastocysts prior to
AA exposure (Figure 10B, C). In contrast, embryos flushed at 130h phCG were able to
spread after culture either with or without AA, and mTOR staining of these embryos
resembled that of in vitro cultured embryos following exposure to AA, when mTOR has
been activated (Figure 10A,B,E). These data indicate that in vivo, the embryo becomes
competent by 120h phCG to respond to environmental conditions by activating mTOR, and
further, that during the period between 120h phCG to 130h phCG changes occur in the
uterine milieu that provide the blastocyst with signals that lead to mTOR activation and
induction of trophoblast motility.
In vitro derived blastocysts can be activated by uterine fluid isolated at 130h phCG
To verify that uterine fluid became competent to activate trophoblast motility by 130h
phCG, we collected uterine fluid from mice at various stages of pregnancy: 48, 60, 96, 120,
130, 142, 154h phCG, and then used it to stimulate in vitro matured 120h phCG embryos
(early blastocysts), the peri-implantation stage known to be competent to receive activation
signals. Embryos cultured in uterine fluid isolated 48–120h phCG fail to become activated,
and exhibit no spreading on fibronectin substrates (Figure 11). However, uterine fluid
isolated at 130h phCG was able to promote trophoblast outgrowth, indicating that it
contained in vivo derived elements capable of activating 120h phCG embryos (Figure 11).
Interestingly, fluid collected at 144h phCG was not able to induce trophoblast outgrowth.
These results confirm that the uterine environment changes very specifically between 120
and 130h phCG to provide a signal to the embryo stimulating the onset of trophoblast
motility.
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Implantation is a central event in mammalian reproduction and is therefore a tightly
regulated and coordinated event. Two independent but concomitant events, uterine
receptivity and embryonic development, must be synchronized in order to ensure efficient
implantation, and thus achieve maximal reproductive success. To enable this
synchronization, an intricate language has evolved allowing the embryo and the uterus to be
in constant communication. The nature of the signals underlying this communication is not
well understood, but both previous work and the results presented here demonstrate that
amino acid activation of mTORC1 is an important aspect of blastocyst activation, in
particular for induction of motile, invasive behavior in the trophectoderm (Martin and
Sutherland, 2001; Martin et al., 2003).
In this paper we demonstrate that of all the amino acids tested, only arginine and leucine are
absolutely required for blastocyst activation. When either arginine or leucine, or both, are
excluded from the culture medium, trophoblast outgrowth on fibronectin, a behavior
indicative of blastocyst activation, is completely inhibited. In addition, arginine and leucine
together are also completely sufficient to induce trophoblast outgrowth. Individually, either
arginine or leucine partially induces blastocyst activation, and together they act additively to
fully induce embryo activation. Interestingly, very similar results have been described for
ovine conceptuses, where leucine and arginine, but not glutamine, are able to promote
proliferation and trophoblast motility (Kim et al., 2011). Our findings differ somewhat from
those reported by Van Winkle et al who found that arginine produced only a small amount
of activation (Van Winkle et al., 2006). This discrepancy can most likely be attributed to
differences in amino acid concentration (0.2mM here vs 0.01mM in that study), and perhaps
to differences in the embryonic state of development. While we used in vitro matured
blastocysts cultured from 40h post-hCG in a simple defined medium, Van Winkle et al. used
in vivo matured, delay of implantation embryos on day 8 of pregnancy, which may have
been exposed to uterine factors that could change their behavior.
Our results confirm early observations that the mouse embryo requires arginine and leucine
(Gwatkin, 1966; Martin and Sutherland, 2001; Naeslund, 1979), but importantly they dissect
out the purpose, parameters, and proteins central to this requirement. Our results suggest that
arginine and leucine have overlapping functions in stimulating trophoblast motility as
demonstrated by their mutual requirement for mTORC1 activity for trophoblast outgrowth.
However, we also demonstrate that arginine and leucine have independent, non-overlapping
functions that are additive in stimulating blastocyst activation. It is possible that this ‘two
key lock’ opened by arginine and leucine serves either as a dual developmental checkpoint
or else as a fine-tuning mechanism for the onset of implantation.
Embryos express a repertoire of amino acid transporters that can change according to
developmental stage. SLC6A14 is a Na+/Cl− dependant transporter capable of forming AA
gradients (Borland and Tasca, 1974; Van Winkle et al., 1985; Van Winkle et al., 2006).
Protein expression of SLC6A14 is specifically upregulated at the blastocyst stage,
coincident with the onset of competence to receive an extrinsic activation signal, and further
increases upon AA exposure. SLC6A14 plays an important role in blastocyst activation. It is
the major transporter for leucine in the blastocyst (Van Winkle et al., 1990a), and
significantly, leucine in particular must be transported via SLC6A14 to contribute to embryo
spreading. Inhibiting leucine uptake through SLC6A14 by treatment with either NO711 or
BCH leads to inhibition of trophoblast outgrowth, which cannot be rescued by increased
leucine uptake through other transporters. Other high-affinity substrates for SLC6A14 such
as isoleucine or methionine (Sloan and Mager, 1999; Van Winkle et al., 1985; Van Winkle
et al., 1988; Van Winkle et al., 2006) cannot substitute for leucine, indicating that there is a
González et al. Page 11













role both for the amino acid and for the action of the transporter. Since SLC6A14 is an
active transporter, it can both concentrate amino acids within the cell and can
simultaneously create a charge gradient by co-transport of 2 Na+ and 1 Cl- ion (Sloan and
Mager, 1999). The concentrative effect was hypothesized to be important in stimulating
uptake of arginine through SLC3A1/SLC7A9, a heterodimeric transporter which functions
as a tightly coupled amino acid antiporter (Martin et al., 2003; Palacin et al., 2005; Van
Winkle, 2001). Our results, however, do not support this hypothesis, as arginine uptake is
not stimulated by addition of leucine, nor is it inhibited either when leucine is not present in
the medium or when leucine uptake through SLC6A14 is inhibited. Furthermore, the
concentration of leucine within the cell does not appear to be the limiting factor, since
uptake of leucine at normal levels through other transporters is not sufficient to induce
trophoblast outgrowth. This suggests that either the changes in intracellular concentration of
Na or Cl, or any resulting changes to the membrane potential may synergize with the
intracellular effects of leucine to induce blastocyst activation.
The timely expression of SLC6A14 at the blastocyst stage serves as a key regulator of
blastocyst activation, bestowing upon the 120h phCG embryo the ability to receive an
activation signal both in vitro and in vivo. In addition to the embryo’s temporal regulation of
SLC6A14, factors related to the onset of uterine receptivity may also act to regulate its
activity in the embryo. For example, a global change in the concentration of leucine in the
uterine milieu could drive uptake and subsequent embryo activation. Alternatively,
concentrations of Na+ in the uterus have been found to increase prior to implantation
(Nilsson and Ljung, 1985; Van Winkle et al., 1983) and since SLC6A14 is a Na+ dependant
transporter, an overall increase in Na+ concentration could directly affect transport activity.
Such an idea is further supported by the finding that blastocysts do not form outgrowths
when Na+ levels are reduced in culture conditions but become activated with increased Na+
concentration (Van Winkle, 1981). These and other scenarios are equally plausible.
Determination of uterine fluid composition at various hours phCG is needed to address this
point and future work will address these possibilities.
It is well documented that AAs, in particular arginine and leucine, activate the serine/
threonine protein kinase mTOR. mTOR can form two biochemically and functionally
distinct complexes, the traditionally rapamycin sensitive mTORC1 and insensitive
mTORC2. While levels of the mTORC2 subunit Rictor are almost undetectable in the
blastocyst, the mTORC1 core component Raptor is preferentially expressed at this stage.
Interestingly, levels of the common component LST8 decrease from oocyte throughout early
preimplantation stages, and are nearly undetectable in the blastocyst. The expression data
support the predominant role for mTORC1 in implantation established in mouse knockouts
for mTOR, Rictor, Raptor, and LST8 (Gangloff et al., 2004; Guertin et al., 2006). Somewhat
different results have been described for ovine embryos, where arginine treatment leads to
increased Akt1 phosphorylation, suggestive of mTORC2 activation (Kim et al., 2011).
In the presence of rapamycin, +AA medium fails to stimulate trophoblast outgrowth,
implicating mTORC1 activity in regulating this behavior (Gangloff et al., 2004; Martin and
Sutherland, 2001). Likewise embryos cultured in +Arg, +Leu, or +Arg+Leu medium in the
presence of rapamycin, fail to exhibit trophoblast outgrowth, placing arginine and leucine,
both individually and in combination, upstream of mTORC1 in the pathway inducing
trophoblast motility. A major function of mTORC1 is to regulate cellular growth by
phosphorylation of two downstream effectors, p70S6K and 4EBP, which in turn increase the
translation of specific populations of mRNAs (De Benedetti and Rhoads, 1990; Koromilas et
al., 1992; Lazaris-Karatzas et al., 1990; Lin et al., 1994; Pause et al., 1994; Shama and
Meyuhas, 1996). The effects of either +Arg or +Leu medium on trophoblast motility require
protein translation but not mRNA transcription during the 8-hour pulse of amino acid
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treatment. These observations suggest that novel proteins are required to promote the
changes in trophectoderm cell motility required for implantation, but that these proteins are
unlikely to be transcription factors that induce new gene expression.
Surprisingly, despite the clear requirement for mTORC1 activity and new translation,
trophoblast outgrowth was not correlated with the activity of either p70S6K or 4EBP, as
measured by their level of phosphorylation by mTORC1. While only moderate levels of
phosphorylation of p70S6K and 4EBP were seen in embryos cultured under conditions that
promote trophoblast outgrowth (+Arg, +Leu, +Arg+Leu), we detected robust amounts of
phosphorylation of both proteins in embryos cultured under conditions where trophoblast
outgrowth is inhibited (-Arg, -Leu, -Arg-Leu). These observations suggest the presence of
novel rapamycin-sensitive actions of mTORC1 independent of both p70S6K and 4EBP1.
This possibility seems quite plausible given that mTOR affects a wide variety of signaling
pathways and cellular processes (Barbet et al., 1996; Di Como and Arndt, 1996; Kunz et al.,
1993; Laplante and Sabatini, 2009a, b). Alternatively, a rapamycin-sensitive mTOR
complex lacking LST8 (mTORC3?) might have alternative downstream targets in the
blastocyst (Fig 12). Only low levels of LST8 are detected in the blastocyst, and embryos
lacking LST8 do implant (Guertin et al., 2006).
mTORC1 has also been shown to play a central role in skeletal myogenesis, independent of
kinase activity and the function of p70S6K and 4EBP (Erbay and Chen, 2001). In this
system mTOR regulates expression of IGF-II through both transcriptional and post-
transcriptional mechanisms (Erbay et al., 2003; Ge et al., 2011). IGF-II is an interesting
candidate as a potential regulator of trophoblast differentiation in that it is preferentially
expressed in TE cells at the time of implantation (Lee et al., 1990), and is known to promote
trophoblast cell differentiation (Kanai-Azuma et al., 1993). However, the mechanisms of
regulation would likely be different in trophoblast cells from those defined during
myogenesis, given that de novo transcription is not necessary for trophoblast outgrowth.
Although mTORC1 has primarily been studied in relation to its effects on cellular growth
and proliferation, effects on motility are not entirely unprecedented. Activation of mTORC1
specifically in keratinocytes leads to accelerated wound healing both in vitro and in vivo
(Squarize et al., 2010) although the precise nature of the pathways responsible for this
behavioral transformation remain elusive. Actin cytoskeletal dynamics are likely involved in
the observed changes in trophoblast cell motility, and although mTORC2 activity is
traditionally thought to affect the cytoskeleton, it remains equally plausible that mTORC1
may also exert significant effects on actin dynamics. Not only does mTORC1 interact with
Rho GTPases, such as P-Rex1, (Hernandez-Negrete et al., 2007) it also plays a role in the
progression and metastasis of colorectal cancer through RhoA and Rac1 activation (Gulhati
et al., 2011). Given the similar cell behaviors during the epithelial to mesenchymal transition
that underlies both metastasis and implantation, it seems possible that activated embryonic
mTORC1 may act in analogous manner to drive trophoblast motility.
While our results provide strong evidence that an activated, rapamycin sensitive mTOR
complex is necessary for blastocyst activation, they also indicate that an activated mTOR
complex is not sufficient. While mTOR is active in embryos cultured in –Arg or –Leu
medium as assessed both by increased p70S6K and 4EBP phosphorylation and by
immunostaining of mTOR (Figs ), these embryos remain unable to form trophoblast
outgrowths. This suggests that while arginine and leucine activate a rapamycin sensitive
mTOR complex that in turn activates translation, these two amino acids also have
independent effects either downstream of or parallel to mTOR signals (Fig 12). Studies of
ovine embryo development suggest a role for polyamines and nitric oxide downstream of
arginine (Kim et al., 2011). Expression of ornithine decarboxylase, a rate-limiting enzyme in
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the production of polyamines from arginine, is highly associated with implantation in the
mouse although inhibition by either chemical (Zhao et al., 2008) or genetic (Pendeville et
al., 2001) approaches does not prevent implantation. IGF-II induces production of the
arginine derived bioactive molecule nitric oxide (NO) (Kaliman et al., 1999; Lee et al.,
1990) which can promote cell motility by modifying cell substrate adhesion (Brown et al.,
2001; Chang et al., 2002; Kaur et al., 1998; Liu et al., 2006). Importantly, disruption of NO
signaling inhibits formation of mouse blastocyst trophoblast outgrowths (Sengoku et al.,
2001). Clearly, further characterization of arginine- and leucine-specific signals will be
important to clarify the pathways regulating motility.
mTOR protein levels remain steady throughout preimplantation development, but its
intracellular localization changes, which may reflect its functional status. Studies in cultured
cell models have shown that amino acids promote activation of Rag GTPases and the
trimeric Ragulator complex, which in turn localize mTOR to the surface of lysosomes where
it can interact with its activator, Rheb cPase (Flinn et al., 2010; Sancak et al., 2010; Sancak
et al., 2008). Through the 8-cell stage, embryos exhibit a diffuse cytoplasmic staining while
morulae and blastocysts show an increasingly punctate perinuclear and plasma membrane-
associated pattern. Embryos treated with +AA showed a substantial increase in mTOR
signal despite no change in total mTOR protein expression, suggesting that amino acid
signals lead either to a change in mTOR conformation, or to a change in association with
other proteins that mask the antigenic epitope. In contrast, no appreciable change in Raptor
signal intensity was observed. Rapamycin treatment does abrogate the increase in mTOR
signal, although there is a modest signal boost. The change in mTOR immunofluorescent
signal occurs very rapidly, within even 1’ of +AA exposure, and remains elevated in
embryos subsequently transferred to –AA medium (data not shown). The change in mTOR
immunofluorescent intensity provides a very powerful tool for monitoring its activation state
in intact embryos, and strongly supports the concept that mTOR activation is a checkpoint in
blastocyst progression to the activated state. Embryos cultured in –AA medium in vitro
remain in a quiescent, non-spreading state, but can be induced to spread with exposure to
AA at any time after 120h phCG (Martin and Sutherland, 2001). The exposure to AA is an
irreversible signal after 4–8 hours, as transfer back to –AA medium does not inhibit the
ability of the embryo to initiate trophoblast outgrowth (Martin and Sutherland, 2001).
Importantly, the difference in timing between mTOR activation (≤1 minute) and the
irreversible induction of trophoblast outgrowth (4–8 hours) also underscores our conclusion
that mTOR activation is necessary but not sufficient for this process.
The mTOR activation checkpoint seen in vitro also occurs in vivo, and exhibits identical
temporal dynamics. Embryos matured in vivo to 96h phCG were unable to form trophoblast
outgrowths following an 8-hour incubation in +AA, similar to in vitro matured embryos
(Martin and Sutherland, 2001). Embryos matured in vivo to 120 h phCG exhibited a non-
activated pattern of mTOR localization and did not spread in the absence of exogenously
supplied AA, but did form trophoblast outgrowths when cultured in +AA medium, again
similar to those matured in vitro. This indicates that although the embryos are competent to
receive an activation signal at 120h phCG, it has not yet occurred in vivo. Conversely, by
130h phCG embryos not only exhibited increased mTOR signal intensity but spread in both
+AA and –AA medium, indicating that an activation signal has occurred in vivo by this
time. These results reveal the in vivo timeline of embryo activation and provide evidence for
a specific change in the uterine milieu that is important for blastocyst activation. Further
evidence supporting a specific, temporally regulated change in the uterine milieu was
obtained by isolating uterine fluid from mice at the same stages of pregnancy. While uterine
fluid from mice at 48–72 h phCG not only failed to produce trophoblast outgrowth, it also
caused the embryos to bleb and appeared apoptotic. While fluid from 120 h phCG uteri was
not toxic to blastocysts it did not stimulate trophoblast outgrowth. Significantly, uterine fluid
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from mice at 130 h phCG promoted trophoblast outgrowth by nearly all blastocysts, but
uterine fluid from mice at 144h phCG was not able to induce trophoblast outgrowth. Thus,
as embryos progress from morning to evening on E4.5, uterine changes occur within a
narrow window of time that induce mTOR activation and the onset of trophoblast motility in
preparation for the initiation of invasion. These uterine changes could include modification
either in amino acid composition, or in the concentration of NaCl, which could in turn drive
increased amino acid uptake. The timing of these changes suggests that they could be a
downstream effect of LIF action on the decidualizing stroma and/or on the uterine
epithelium (Ramathal et al., 2010). Alternatively, interaction of the embryo with uterine-
derived soluble signals, such as Wnt4 (Franco et al., 2011) or with HB-EGF on the uterine
epithelium (Das et al., 1994a) may lead to intracellular signals regulating the localization or
activity of SLC6A14. In particular, HG-EGF has been shown to induce calcium influx
leading to accelerated trophoblast differentiation (Wang et al., 2000), and the SLC6A14
transporter has two consensus sites for phosphorylation by Protein Kinase C (PKC) and one
for phosphorylation by CamKII which may affect its function (Sloan and Mager, 1999). In
this way, attachment of the embryo to the uterine epithelium could conceivably facilitate
transduction of the signal to initiate invasion.
Our data suggest that activation of trophoblast motility is independent of the process of
apposition and attachment. Previous studies have identified a uterine signal required for
initiation of apposition and attachment of the embryos to the uterine epithelium, which
occurs in the late afternoon of E3.5, and leads to the onset of attachment by midnight of that
evening (E4.0) (Das et al., 1994b; Paria et al., 1993a; Song et al., 2000). In vitro, blastocysts
exhibit increased integrin trafficking to the plasma membrane and subsequently acquire the
ability to become adhesive as exhibited by binding to fibronectin beads (Schultz and
Armant, 1995; Schultz et al., 1997; Wang et al., 2002; Yelian et al., 1995). These changes in
integrin distribution and fibronectin binding occur even in the absence of an AA signal
(Martin and Sutherland, 2001), illustrating that the lack of trophoblast spreading in –AA
conditions does not arise from an inability to become adhesive, but rather from an inability
to initiate motility. Consistent with the in vitro results, we show here that the onset of
motility is not induced in vivo until at least 10 hours after the onset of attachment,
suggesting a two-step process by which the uterus signals to the embryo to promote
implantation. Our results suggest that the second signal may result in changes in uptake of
amino acids by the embryos, particularly of leucine and arginine, which in turn both activate
mTORC1 and act independently and additively to induce trophoblast motility.
Highlights
Arginine and leucine are necessary and sufficient to induce trophoblast motility. Arginine
and leucine have both mTORC1-dependent and independent actions. p70S6K or 4EBP
activity do not correlate with motility suggesting a separate pathway. In vivo mTOR
activation suggests uterine factors induce mTORC1 regulated motility. Amino acids may
be components of the in vivo uterine-embryo implantation crosstalk.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Arginine and leucine are necessary and sufficient for trophoblast outgrowth
A. Graph showing the percent of embryos exhibiting any trophoblast outgrowth
following 8 hours of culture in medium containing all amino acids except the
indicated ones: arginine and/or leucine (−Arg, −Leu, −Arg-Leu); Isoleucine (−Iso),
Threonine (−Thr), Histidine (−His), Tyrosine, (−Tyr), Lysine (−Lys), Glutamine
(−Gln).
B. Graph showing the percent of embryos exhibiting any trophoblast outgrowth
following 8 hours of culture in medium containing no amino acids except the
indicated ones: 0.2mM arginine (+Arg) or 0.2mM leucine (+Leu) or both in
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combination (+Arg+Leu); Isoleucine (+Iso), Threonine (+Thr), Histidine (+His),
Tyrosine, (+Tyr), Lysine (+Lys), Glutamine (+Gln).
For both graphs A and B, the data represent the mean +/− SEM for 6 independent
experiments. Mean values labeled with different letters are significantly different from one
another, P ≤ 0.01
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Figure 2. SLC6A14 protein expression is temporally regulated and its activity is critical for
trophoblast outgrowth
A. Western blot of whole cell lysates of 100 embryos at the indicated stages, and of
normal mouse lung as a control, probed with an antibody against SLC6A14 then
probed with an antibody to tubulin as a loading control. (Mor: Morula,
Blast:Blastocyst)
B. Graph showing the percent of embryos exhibiting any trophoblast outgrowth
following 8 hours incubation in the media indicated. The data in the first three bars
represent toxicity controls, where embryos were incubated for 8 hours in +AA
medium with or without NO711 or BCH, washed and then transferred to +AA
medium on fibronectin. All other embryos were incubated for 8 hours in medium
containing the indicated amino acids, with or without NO711 or BCH, and then
transferred into – AA medium on fibronectin. The data represent the mean +/−
SEM of 6 independent experiments. Mean values labeled with different letters are
significantly different from one another, (p ≤ 0.01).
C. Blastocyst uptake of [3H]arginine and [3H]leucine following 8 hours incubation in
the indicated media. The number under each bar corresponds to the number on the
list to the right of the graph showing the medium used and the color of the bar
represents the amino acid measured in that condition. The data represent the mean
+/− SEM of 3 independent experiments performed in triplicate. Mean values
labeled with different letters are significantly different from one another, (p ≤
0.01).
D. Blastocyst up take of [3H]arginine and [3H]leucine following 8 hours incubation in
media containing the SLC6A14 inhibitors BCH or NO711. The letter under each
bar corresponds to the letter on the list to the right of the graph indicating the
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medium used and the color of the bar represents the amino acid measured in that
condition. The data represent the mean +/− SEM of 3 independent experiments
performed in triplicate. Mean values labeled with different letters are significantly
different from one another, (p ≤ 0.01).
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Figure 3. Increased leucine uptake via other amino acid transporters does not produce
trophoblast outgrowth
A. Graph showing mean uptake of [3H]leucine by blastocysts following 8 hours
incubation in medium containing increasing concentrations of leucine with or
without NO711.
The data represent the mean +/− SEM of 3 independent experiments performed in
triplicate.
Bars labeled with different letters are significantly different from one another, (p ≤
0.01)
B. Graph showing percent of embryos exhibiting any trophoblast outgrowth after 8
hours of incubation in the indicated medium.
For both graphs, the data represent the mean +/− SEM of 3 independent experiments
performed in triplicate.
Mean values labeled with different letters are significantly different from one another, (p ≤
0.01)
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Figure 4. mTOR activation and protein translation are necessary for arginine- or leucine-
stimulated trophoblast outgrowth, but RNA transcription is not
A. Graph showing the percent of embryos exhibiting trophoblast outgrowth following
8 hours incubation in medium containing the indicated amino acids in combination
with rapamycin (Rapa).
B. Graph showing the percent of embryos exhibiting trophoblast outgrowth following
8 hours incubation in medium containing the indicated amino acids in combination
with cycloheximide (CHX).
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C. Graph showing the percent of embryos exhibiting trophoblast outgrowth following
8 hours incubation in medium containing the indicated amino acids in combination
with alpha-amanitin.
For all graphs, the data represent the mean +/− SEM from 4 independent experiments. Mean
values labeled with different letters are significantly different from one another (p ≤ 0.01).
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Figure 5. Phosphorylation of TORC1 downstream effectors p70S6K or 4EBP does not correlate
with embryo spreading
A. Western blot of whole-cell lysates of 100 embryos (per lane) cultured for 8 hours in
the indicated medium, probed sequentially for phospho-Thr389 p70S6K and
phospho-Thr37/46 4EBP, then for the total amount of p70S6K and 4EBP, and
finally for tubulin as a loading control.
B. Western blot of whole-cell lysates of 100 embryos cultured for 8 hours in the
indicated medium, probed sequentially for phospho-Ser64 4EBP and for tubulin as
a loading control.
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C. Graphical representation of the percentage of p70S6K that is phosphorylated at Thr
389 and of 4EBP that is phosphorylated at Thr37/46 or Ser 64, normalized to
tubulin for each sample. These values are derived from quantitation of the blots
shown in A and B, which are consistent with other blots done on these same
treatment groups.
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Figure 6. The TORC1 components mTOR and Raptor are preferentially expressed in the
blastocyst
Western blot of whole-cell lysates (WCL) of 100 embryos (per lane) at the indicated stages,
and of the rat choriocarcinoma cell line (Rcho-1) and the human embryonic kidney cell line
S293 (293S), probed simultaneously with antibodies against mTOR, Rictor, Raptor, and
LST8, and then probed with an antibody against tubulin as a loading control. (Mor, Morula;
Blast, Blastocysts)
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Figure 7. mTOR localization in oocytes and peri-implantation embryos
Immunofluorescent localization of mTOR and DAPI within the oocyte, and in embryos at
48h (2-cell) and 68h (8-cell), 96h (morula), and 120h phCG (blastocyst). The images are
extended focus composites of confocal Z-stacks. Control is secondary antibody alone with
DAPI staining.
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Figure 8. Immunofluorescent signal intensity from Cell Signaling Technology (CST) antibody
#2983 increases upon amino acid-stimulated mTOR activation
A. Unstimulated (−AA, 8 hours) 120h phCG blastocyst…
B. Amino acid stimulated (+AA, 8 hours) 120h phCG blastocyst.
C. Amino acid and Rapamycin (+AA/Rapamycin, 8 hours) treated 120h phCG
blastocyst.
D. Increased mTOR signal intensity in 120h phCG embryo stimulated with amino
acids for 1’.
E. Increased mTOR signal intensity in 120h phCG embryo stimulated with amino
acids for 5’.
F. Increased mTOR signal intensity in 120h phCG embryo stimulated with amino
acids for 10’.
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G. Unstimulated (−AA, 8 hours) 120h phCG blastocyst stained with antibody to
Raptor.
H. Amino acid stimulated (+AA, 8 hours) 120h phCG blastocyst stained with antibody
to Raptor.
I. Secondary antibody alone control with DAPI staining.
J. Western blot showing the protein levels of mTOR and Raptor in stimulated and
unstimulated embryos (+AA and −AA; 100 embryos per lane).
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Figure 9. Activated mTOR localization assessed by Cell Signaling Technoly (CST) antibody
#2983 in embryos cultured in various arginine and leucine containing media
Increased mTOR signal intensity indicative of an activated mTORC1 in blastocysts after
amino acid stimulation in the indicated media. Control is unstimulated blastocyst (−AA, 8
hr) stained for mTOR and DAPI.
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Figure 10. In vivo embryos receive an activation signal between 120h and 130h phCG
A. Graph showing the percent of embryos flushed from the uterus at 96h, 120h, or
130h phCG that form trophoblast outgrowths following culture in either +AA or
−AA medium in vitro. (N=32 embryos 96h phCG +AA; N= 29 embryos 96h phCG
−AA; N= 37 embryos 120h phCG +AA; N=30 embryos 120h phCG −AA; N= 35
embryos 130h phCG +AA; N= 30 embryos 130h phCG −AA).
B. Graph showing the percent of blastocysts flushed from the uterus at either 120h or
130h phCG that exhibit localization of mTOR in a pattern characteristic of either
the inactivated or activated state. (N=9 embryos 120h phCG; N=15 embryos 130h
phCG)
C. mTOR immunofluoresence of blastocyst flushed from the uterus at 120h phCG.
D. mTOR immunofluoresence in a blastocyst flushed from the uterus at 130h phCG,
characteristic of the inactivated mTOR signal intensity
E. mTOR immunofluoresence in a blastocyst flushed from the uterus at 130h phCG,
characteristic of the activated mTOR signal intensity
F. Secondary antibody alone with DAPI staining
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Figure 11. 130h phCG uterine fluid stimulates trophoblast outgrowth
Graph showing the percent of embryos exhibiting any trophoblast outgrowth following 24
hours of culture in uterine fluid collected from mice at the indicated stages of pregnancy.
Embryos were flushed at 48h phCG, cultured in vitro to the blastocyst stage, and used in
trophoblast spreading assays when they were at 120h phCG. Data represent the mean +/−
SEM of 3 independent experiments. N= 45 embryos per treatment.
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Model for the action of amino acids on trophoblast cells at the time of implantation.
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Table 1
Developmental stage of peri-implantation embryos and corresponding hour post hCG (h phCG). Table
summarizing the developmental stages of in vitro matured mouse embryos normalized against second





2 Cell 48h phCG
8 Cell 60h phCG
Morulae 72h phCG
Cavitating Morulae 96h phCG
Early Blastocyst 120h phCG
Mid Blastocyst 130h phCG
Late Blastocyst 154h phCG
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